Searched for
NOVARTIS ACQUISITION
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Citi sees India IPOs hitting fresh records despite challengesIndian initial public offerings are poised for a strong comeback in the latter half of the year. Citigroup anticipates deal volumes to meet...
- Novartis to buy experimental breast cancer drug in up to $3 billion dealSwiss drugmaker Novartis is set to acquire a promising breast cancer drug candidate from US biotech firm Synnovation Therapeutics. The deal...
- Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore dealNovartis India shares surged nearly 18% after its Swiss parent announced the sale of its 70.68% stake for approximately Rs 1,446 crore. A c...
- Novartis to acquire Avidity Biosciences for about $12 billionNovartis is acquiring U.S. biotech firm Avidity Biosciences for approximately $12 billion in cash to expand its rare disease treatment port...
- Novartis to buy Tourmaline Bio for $1.4 billionNovartis AG is set to acquire Tourmaline Bio for $1.4 billion, aiming to bolster its drug pipeline amid upcoming generic competition for ke...
- Torrent completes acquisition of Novartis brandsLast month, Torrent had announced inking of pacts with Novartis AG to acquire the two brands.Torrent Pharma shares today ended 0.27 per cen...
- Torrent close to buying women healthcare portfolio of Swiss pharma major NovartisSources say cos have already signed a business transfer deal for the domestic women healthcare portfolio, which is worth around Rs 300 cror...
- GSK Pharma completes deal with Novartis HealthcareDrug firm GlaxoSmithKline Pharmaceuticals has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis...
- Dr Reddy's acquires Habitrol brandDr Reddy's Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from Novartis Consumer Health Inc.
- Novartis buys GSK's cancer drugs for $14.5 billion in a 3-way dealThe collaboration between the two will create a new world-leading consumer healthcare business with $10 billion in annual sales.
- Novartis revamps pharma world with mega-deals with GSK, Eli LillyThe Swiss drugmaker said it would divest its vaccines business, excluding flu, to GSK for $7.1 million plus royalties.
- Novartis bids $ 470 mn for US cancer diagnostic firmIt says the price represents a 39 per cent premium over Genoptix's share value on Dec. 13, 2010, when rumors of a sale sparked a price surg...
- Novartis concludes acquisition of 77% Alcon stake from NestleNovartis on Thursday said it has concluded a $28.3 billion deal with Alcon Inc that will give the Swiss drug-maker a controlling stake in t...
- Novartis raises stake in Indian arm to 76.42 pcSwiss drug maker Novartis AG has hiked its stake to 76.42 per cent in its Indian subsidiary Novartis India pursuant to the completion of op...
- Novartis soars 20 pc as Swiss parent sweetens offer priceSwiss drug firm Novartis AG sweetened its open offer price to Rs 450 a share for acquiring an additional 39 per cent stake in its Indian su...
- Novartis open offer for Indian arm to begin on May 20Swiss Drug maker Novartis AG's open offer for acquiring an additional 39 pr cent stake in its Indian subsidiary will begin on May 20.
- Novartis open offer for Indian arm to begin on May 14Swiss drug maker Novartis AG's open offer for acquiring an additional 39 per cent stake in its Indian subsidiary will begin on May 14.
- Novartis eyes buy-out of biopharma firm SpeedelSwiss pharmaceutical giant Novartis said it had boosted its stake in biopharmaceutical firm Speedel by 51.7 per cent and aimed to buy it ou...
- Novartis eyes share buy backsWhen asked whether Novartis was interested in buying U.S. biotechnology firm MedImmune , Vasella said biotech firms were "on our radar scre...
Load More
